Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Stroke. 2019 Apr;50(4):1021–1025. doi: 10.1161/STROKEAHA.118.024287

Figure 1. Efficacy of novel NKCC1 inhibitors in reducing ischemic infarction and cerebral edema in mice after t-MCAO.

Figure 1.

(A) Experimental protocol in normotensive mice and representative TTC staining images. (B) Infarct and swelling. Data are mean ± SD, n = 6-15 (male, n = 3-9; female, n = 3-6), * p < 0.05. (C) Mice treated with drugs at an equimolar dose of 2 mg/kg BMT. Data are mean ± SD, n = 5-9 (male, n = 3-5; female, n = 2-4).